LMLN and infection: The researchers demonstrated that gp63 DNA based vaccination induced immune responses and conferred protection against challenge infection, while HPB based on gp63 in association with the vaccine adjuvant Cpg ODN emphasized cellular and humoral responses that correlated with durable protection against a challenge with L. donovani up to 12 weeks post vaccination.